Press Releases

Date Title  
Toggle Summary AUDENTES THERAPEUTICS RAISES $30 MILLION IN SERIES A FINANCING
Funding creates premier global biotechnology company dedicated to the development of treatments for rare muscle diseases using gene therapy technology SAN FRANCISCO, CA. – July 18, 2013   – Audentes Therapeutics Inc., a recently founded biotechnology company dedicated to the development of